Amyotrophic lateral sclerosis in Piedmont (Italy): A Bayesian spatial analysis of the incident cases

References

• Chiò A, Magnani C, Schiffer D. Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study. Neurology. 1993;43:927–30.
   PubMed Web of Science ®Google Scholar
• Durrleman S, Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real?Neurology. 1989;39:768–73.
   PubMed Web of Science ®Google Scholar
• Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001;56:239–44.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995 − 1997: a population based study. Neurology. 1999;52:504–9.
   PubMed Web of Science ®Google Scholar
• Bastos AF, Orsini M, Machado D, Mello MP, Nader S, Silva JG, . Amyotrophic lateral sclerosis: one or multiple causes?Neurol Int. 2011;3(1):e4.
   Google Scholar
• Miranda ML, Alicia Overstreet Galeano M, Tassone E, Allen KD, Horner RD. Spatial analysis of the aetiology of amyotrophic lateral sclerosis among 1991 Gulf War veterans. Neurotoxicology. 2008;29:964–70.
   PubMed Web of Science ®Google Scholar
• Doi Y, Yokoyama T, Tango T, Takahashi K, Fujimoto K, Nakano I. Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995 − 2004. J Neurol Sci. 2010;298:78–84.
   PubMed Web of Science ®Google Scholar
• Sabel CE, Boyle PJ, Löytönen M, Gatrell AC, Jokelainen M, Flowerdew R, . Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. Am J Epidemiol. 2003;157:898–905.
   PubMed Web of Science ®Google Scholar
• Turabelidze G, Zhu BP, Schootman M, Malone JL, Horowitz S, Weidinger J, . An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998 − 2002. Neurotoxicology. 2008;29:81–6.
   PubMed Web of Science ®Google Scholar
• Uccelli R, Binazzi A, Altavista P, Belli S, Comba P, Mastrantonio M, . Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol. 2007;22:781–90.
   PubMed Web of Science ®Google Scholar
• Chiò A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, . Epidemiology of ALS in Italy: a 10-year prospective population based study. Neurology. 2009;72: 725–31.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci. 1994;124(Suppl): 96–107.
   PubMed Web of Science ®Google Scholar
• Banca Dati Demografica Evolutiva della Regione Piemonte (BDDE), http://www.regione.piemonte.it/stat/bdde/info/principi.htm.
   Google Scholar
• StataCorp. Statistical Software: Release 9.0. College Station, TX: Stata Corporation. 2005.
   Google Scholar
• Besag J, York J, Mollie A. Bayesian Image-Restoration, with two Applications in Spatial Statistics. Annals of the Institute of Statistical Mathematics. 1991;43:1–20.
   Web of Science ®Google Scholar
• Smith BJ. BOA: an R package for MCMC output convergence assessment and posterior inference. Journal of Statistical Software. 2007;21:1–37.
   Web of Science ®Google Scholar
• Cowles MK. P. Markov chain Monte Carlo convergence diagnostics: a comparative review. Journal of the American Statistical Association. 1996;91:883–904.
   Web of Science ®Google Scholar
• Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS: a Bayesian modelling framework. Concepts, structure, and extensibility. Statistics and Computing. 2000;10: 325–37.
   Google Scholar
• Chiò A, Borghero G, Pugliatti M, Ticca A, Calvo A, Moglia C, . Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. Arch Neurol. 2011;68:594–8.
   PubMedGoogle Scholar
• Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22: 217–28.
   PubMed Web of Science ®Google Scholar
• Chiò A, Calvo A, Moglia C, Mazzini L, Mora G, PARALS study group. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740–6.
   PubMed Web of Science ®Google Scholar
• Mitchell JD. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:235–50.
   PubMed Web of Science ®Google Scholar
• Fernandez C, Green PJ. Modelling spatially correlated data via mixtures: a Bayesian approach. Journal of the Royal Statistical Society Series B-Statistical Methodology. 2002; 64:805–26.
   Google Scholar
• Lambert D. Zero-Inflated Poisson Regression, with an Application to Defects in Manufacturing. Technometrics. 1992;34:1–14.
   Web of Science ®Google Scholar
• Lawson AB, Clark A. Spatial mixture relative risk models applied to disease mapping. Statistics in Medicine. 2002;21:359–70.
   Web of Science ®Google Scholar
• Banack SA, Murch SJ. Multiple neurotoxic items in the Chamorro diet link BMAA with ALS/PDC. Amyotroph Lateral Scler. 2009;10(Suppl 2):34–40.
   Google Scholar
• Bradley WG, Mash DC. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph Lateral Scler. 2009;10 (Suppl 2):7–20.
   PubMedGoogle Scholar
• Morahan JM, Pamphlett R. Amyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case control study. Neuroepidemiology. 2006;27:130–5.
   PubMed Web of Science ®Google Scholar
• Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, . Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:623–7.
   PubMed Web of Science ®Google Scholar
• Chiò A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, . Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9orf72. Brain. 2012;135:784–93.
   PubMed Web of Science ®Google Scholar
• Sabatelli M, Conforti FL, Zollino M, Mora G, Monsurrò MR, Volanti P, . C9orf72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol Aging. 2012;33:1848.e15–20.
   PubMed Web of Science ®Google Scholar
• Mok K, Traynor BJ, Schymick J, Tienari PJ, Laaksovirta H, Peuralinna T, . The chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiology of Aging. 2012;33:e3–8.
   Google Scholar
• Forbes Colville S, Parratt J, Swingler RJ. The incidence of motor neuron disease in Scotland. J Neurol. 2007;254:866–9.
   Google Scholar
• Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G, SLALOM Group. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141–5.
   PubMed Web of Science ®Google Scholar
• Simpson CL, Al-Chalabi A. Amyotrophic lateral sclerosis as a complex genetic disease. Biochimica Et Biophysica Acta-Molecular Basis of Disease. 2006;1762:973–85.
   PubMed Web of Science ®Google Scholar